Palvella Therapeutics (PVLA) Return on Invested Capital (2014 - 2015)
Palvella Therapeutics' (PVLA) quarterly Return on Invested Capital came in at 0.13% in Q3 2015, up 32.0% year-on-year from 0.1% in Q3 2014, and down 3.16% on a QoQ basis from 0.13% in Q2 2015.
Palvella Therapeutics (PVLA) Return on Invested Capital (2014 - 2015) Analysis & Trends
Palvella Therapeutics (PVLA) has 2 years of Return on Invested Capital data on file, last reported at 0.13% in Q3 2015.
- On a quarterly basis, Return on Invested Capital rose 32.0% year-over-year to 0.13% in Q3 2015; TTM through Sep 2015 was 0.13%, a 32.0% increase from a year earlier, with the FY2014 full-year figure at 0.11%, changed N/A from the prior year.
- Return on Invested Capital for Q3 2015 stood at 0.13%, down from 0.13% in the prior quarter.
- Over the last five years, Return on Invested Capital for PVLA reached as high as 0.1% in Q1 2015 and fell as low as 0.45% in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | -0.13% |
| Jun 30, 2015 | -0.13% |
| Mar 31, 2015 | -0.10% |
| Sep 30, 2014 | -0.45% |
| Jun 30, 2014 | -0.20% |